CADENCE PHARMACEUTICALS INC. CADX (NASDAQ)

$ 6.07
11/18/2008 24:00
Sponsored by
Click here!
Change: unch (unch%)
Volume: 88,767

Avg. Volume: 165223
P/E Ratio: 0
EPS (Annual): -1.78
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 38,350
Institutional Shareholders: 39.51%
Last: 6.07
Change: unch (unch%)
Prev. Close: 6.07
Open: 5.90
Day's Range: 5.90 - 6.40
52wk Range: 4.84 - 15.70
Market Value: 234,350
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -52.05%
Total Return Last 3 Years: -26.30%
Total Return Last 5 Years: -35.43%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on CADX

FDA says Cadence Pharma drug ready for review

(NEW YORK)Shares of Cadence Pharmaceuticals soared Thursday after drug developer said it has completed the major studies necessary to seek U.S. approval for its experimental pain and fever t...READ MORE
Jul 31, 2008 3:54PM
Keywords: CADX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -26.00 16.29
JOHNSON AND JOH -10.00 60.89
BRISTOL MYERS S -19.90 20.49
SCHERING PLOUGH -41.00 15.74
MERCK CO INC -54.80 26.13